Oct. 14, 2014, a five-member delegation from Deutsche Bank, led by Mr. Douglas Morton, head of Asia Investment Banking, and Ms. Gao Yiwen, managing director of China Investment Banking, paid a visit to China Sinopharm International Corporation (Sinopharm International). Ms. Shi Shengyi, board secretary of Sinopharm HQ and chairwoman of Sinopharm International, president Li Can and vice president Chen Yudong, Sinopharm International, and Mr. Ding Haiyun, deputy director of Dept. of International Cooperation & Public Affairs, Sinopharm HQ, met with the guests.
Ms. Shi extended the welcome to Mr. Douglas Morton and his team. Mr. Li Can presented the overview of Sinopharm International and its overseas business.
Mr. Douglas Morton expressed his gratitude to the warm welcome from Sinopharm International and introduced the Deutsche Band and the outbound investment business. Ms. Gao Yiwen demonstrated the globally medical resources Deutsche Bank owns and several recent investment programs in this area.
During the meeting, both parties sufficiently exchanged opinions on strategy of outbound M&A, potential opportunities and challenges and considerations of M&A transactions, etc., expressed the willingness of keeping close contact, increasing mutual understanding and interaction, to explore overseas investment opportunity together in the future. [Reported by Sinopharm International]